Abstracts

Previous | 1 | 2 | 3 | 4 | Next  Move down


  1. Höschl C., Praško J. Management of depressed patients with sexual dysfunction. WPA Bulletin on Depression World Psychiatry Association. 2004 9(28):11-14.
  2. Horáček J., Beránek M., Kopeček M., Höschl C., Španiel F.: COMT gene polymorphism and brain metabolism (18FDG PET) in schizophrenia. WIIth Biennal Winter Workshop on Schizophrenia, Davos, Switzerland, 7-13 February 2004. In: Schizophrenia Research 2004, p. 55. ISSN 0920-9964. Supported by the grant CNS LN00B122 MŠMT and IGA NF/6033-3/2000 MZ ČR.
  3. Höschl C., Šťastný F.: Buněčné mechanizmy neurodegenerativních změn v diskonekčním modelu schizofrenie. (Cellular mechanisms of neurodegenerative changes in disconnection model of schizophrenia). Core symposium on "Mortality and morbidity of schizophrenia". Abstracts of 47th Czech-Slovak psychopharmacological conference in Jeseník Spa, January 5-9, 2005). Psychiatrie, 9;2005,S1:17.
  4. Höschl C.: Blockade of 5-HT2 receptors and inhibition of serotonine reuptake: physiology, pharmacology and clinical sequellae. Symposium of Medicom company "SARI–dual model of antidepressant action". Abstracts of 47th Czech-Slovak psychopharmacological conference in Jeseník Spa, January 5-9,2005. Psychiatrie, 9;2005,S1:54.
  5. Horáček J., Novák T., Kopeček M., Španiel F., Dockery C., Höschl C.: Detection of neural plasticity offered by positron emission tomography (PET). 13th AEP Congress, Münich, Germany 1-6 April, 2005. European Psychiatry, 20, 2005, Suppl.1: S-07-02.
  6. Höschl C.: Mirtazapin - relevance of its mechanism of action in clinical practice. Symposium of Zentiva company. Proceedings of the XIIth Czech-slovak psychiatric meeting, December 1-4, High Tatras, Slovakia. Psychiatria pre prax, 6; 2005, S1:29. ISSN 1335-9584.
  7. Höschl C.: Consequences of the 5-HT2A blockade combined with serotonine re-uptake inhibition. Symposium sponsored by Medicom international. XII. Czech-Slovak psychiatric meeting, High Tatras, Slovakia, Dec. 1-4,2005. Psychatria pre prax, 6; 2005, S1:30.
  8. Höschl C.: New pharmacological approaches to the treatment of depression. Abstracts of 48th Czech-Slovak psychopharmacological conference in Jeseník Spa. 4.-8.1.2006. Psychiatrie, 10, 2006, S1:38-40.
  9. Bareš M., Kopeček M., Stopková P., Preiss M., Vonásková K., Seifertová D., Höschl C.: Prague Psychiatric Centre unit for the treatment of a resistant depression: from clinical practice to research. Psychiatrie, 10, 2006; S1:56.
  10. Stopková P., Novák T., Růžičková M., Fridrichová H., Höschl C. A register of bipolar patients. Psychiatrie 10, 2006; S1:69.
  11. Španiel F., Tintěra J., Hájek T., Horáček J., Dezortová M., Hájek M., Dockery C., Kožený J., Höschl C.: Language lateralization in monozygotic twin pairs concordant and discordant for schizophrenia. A fMRI pilot study. Schizophrenia research, 81: 151-152, Suppl S Jan 2006.
  12. Höschl C.: The role of serotonin and its modulation in the treatment of schizophrenia. Czech-Slovak symposium on Progress in neurobiology of schizophrenia and current therapeutic choice. 24.-26.2.2006, Lednice na Moravě, p. 6.
  13. Höschl C. and Stopková P. discerete and continuous in the concept of psychoses. Proceedings of the 3rd symposium on the "progress in the care of the most serious mental illnesses", Olomouc 29-30 april 2006, pp. 87-107.
  14. Bareš M., Brunovský M., ..., Höschl C.: Prefrontal activity changes as a predictor of treatment response to various antidepressants in treatment resistant depressed patients. In: Raboch J., Zrzavecká I., Doubek P.(eds.): Suffering soul-disordered brain: clinical experience and data. Proceedings of the VI. meeting of the Czech psychiatric society. Galén, Praha 2006, pp.1-3. ISBN 80-7262-420-2.
  15. Höschl C.: Freud and contemporary medicine (in Czech). Psychiatria pre prax, 6; 2006, S1:17
  16. Šťastný F., Höschl C. Genes and schizophrenia: past, presence, and future. Sympozium Glutamatergic Neurotransmission and Schizophrenia.International Congress "Molecular Basis of Neurological and Psychiatric Disorders", Slovensko, Martin, 6.-10.9.2006.Sborník abstrakt JLF UKo,Martin. str. 98, 2006.
  17. Šťastný F., Kozmiková-Skuba I., Lisý V., Mareš V., Tejkalová H., Höschl C., Balcar VJ. Emerging role of NMDA receptors in animal models of schizophrenia. Sympozium Glutamatergic Neurotransmission and Schizophrenia.International Congress "Molecular Basis of Neurological and Psychiatric Disorders", Slovensko, Martin, 6.-10.9.2006. Sborník abstrak JLF UKo Martin, str. 99, 2006.
  18. Höschl C., Motlova L. Psycho-education in management of schizophrenia. Eur Neuropsychopharmacol, 16; 2006,S4:165-166
  19. Horacek J., Spaniel F., Novak T., Kopecek M., Mohr P., Höschl C.: Regional brain metabolism (18FDG PET) and polymorphisms for candidate genes in schizophrenia: from SNPs to phenotypes. Eur Neuropsychopharmacol, 16; 2006, S4:184
  20. Höschl C.: Neurbiology of anxiety. Abstracts of the VI World Congress of Depressive Disorders, Mendoza, Argentina, 27-30 September 2006, p. 34.
  21. Brunovský M., Bareš M., Kopeček M., Stopková P., Novák T., Tišlerová B., Šóš P., Kožený J., Höschl C.: New methods of EEG analysis (cordance and EEG tomography) in early prediction of response to antidepressants. Psychiatrie 11, 2007; S1:21
  22. Höschl C.: Schizophrenia, antipsychotics and metabolic changes. Zbornik predavanj, Schizofrenija VI. Slovinsko, Ljubljana, Březen 2007, str. 9.-16.
  23. Höschl C.: The views of European Psychiatrists represented in the AEP. Presidential forum on European Strategy for Mental Health. Abstract for oral sessions. European Psychiatry, 22, 2007, S1:11.
  24. Höschl C.: Ethics of publication. Presidential symposium on Ethics in psychiaty. Abstract for oral sessions. European Psychiatry, 22, 2007, S1:28.
  25. Praško J., Höschl C.: Using multimedial tools, role playing and videofeedback in the training of case management. Abstract for poster sessions. European psychiatry, 22, 2007 S1:212.
  26. Praško J., Horáček J., Záleský R., Kopeček M., Novák T., Pašková B., Skrdlantová L., Bělohlávek O., Höschl C.: Brain 18FDG pet in panic disorder during the treatment with CBT or antidepressants. Abstract for poster sessions. European psychiatry, 22, 2007 S1:286
  27. Brunovský M., Horáček J., Bareš M. Kopeček M., Tišlerová B., Šóš P.,Krajča V. Höschl C.: Renaissance of quantitative electroencephalography (QEEG) in psychiatry. Abstract for poster sessions. European psychiatry, 22, 2007 S1:313.
  28. Horáček J., Brunovský M., Klírová M., Novák T., Škrdlantová L., Kopeček M., Španiel F., Höschl C.: The effect of low-frequency rTMS on regional brain metabolism (PET) in auditory hallucinations as the background for neuronavigated rTMS. Abstract for poster sessions. European psychiatry, 22, 2007 S1:315.
  29. Höschl C., Horáček J., Kopeček M., Bubeníková-Valešová V. Antipsychotics: Mode of action highlight. Symposium: Antipsychotics: Mode of action highlights. Abstract for oral session. European psychiatry, 22, 2007 S1:5.
  30. Höschl C.: Green Paper and Limits of Psychiatry as a Medical Discipline. Syllabus & Proceedings, American Psychiatric Association 2007 Annual Meeting, p.309-310.
  31. Höschl C.: Freud and contemporary medicine. 42nd Congress of Polish psychiatrists, Szczecin, 14-16 June 2007 (invited plenary lecture). Psychiatria Polska, 61, 2007; 3:58.
  32. Höschl C. Pathways of Integrated Medical Curriculum. Surg Radiol Anat. 2007 Aug;29(6):423
  33. Höschl C.: Trends in schizophrenia research from the European perspective. Workshop: Network research in schizophrenia - a European perspective? 1st European Conference on Schizophrenia Research, 26-28 September 2007, Düsseldorf, Germany. Eur Arch Psych Clin Neurosci, 251; 2007, Suppl. 1:11
  34. Höschl C. Metabolic effects of antipsychotics. Proc. Cambridge/Luton Intl. Conference on Mental Health. Psychiat Danub, 19, 2007; S1:8
  35. Šťastný F, Höschl C. Genetické aspecty dysregulace glutamátergního systému u schizofrenie (Abstract). Alkoholizmus a drogové závislosti 2007;2007(Suppl. 1):15. Šťastný F, Höschl C. Genetic aspects of glutamatergic dysregulation in schizophrenia (abstract). Alkoholizmus a drogové závislosti 2007;2007(Suppl. 1):15.
  36. Höschl C., Stopková P.: Discrete and continuous approach in the conceptualization of psychoses. Annals of General Psychiatry, 2008, 7(suppl 1):S41
  37. Höschl C., Španiel F.: Art and science. Invited plenary lecture. 50th Annual Czech-Slovak Psychopharmacological Meeting, Jeseník Spa, 9-13 Jan 2008. Psychiatrie, 12; 2008, S1:11.
  38. Horáček J., Bubeníková-Valešová V., Páleníček T., Kopeček M., Mohr P., Brunovský M., Tišlerová B., Klírová M., Höschl C. Neurobiological lmechanisms of action of antipsychotics.50th Annual Czech-Slovak Psychopharmacological Meeting, Jeseník Spa, 9-13 Jan 2008. Psychiatrie, 12; 2008, S1:14.
  39. Höschl C.: Non-monoaminergic modes of antidepressant action. 50th Annual Czech-Slovak Psychopharmacological Meeting, Jeseník Spa, 9-13 Jan 2008. Psychiatrie, 12; 2008, S1:17.
  40. Höschl C.: Neurobiology of anxiolytic activity. 50th Annual Czech-Slovak Psychopharmacological Meeting, Jeseník Spa, 9-13 Jan 2008. Psychiatrie, 12; 2008, S1:9..
  41. Španiel F., Hrdlička J., Novák T., Motlová L., Höschl C.: ITAREPS: programme of prevention of a relapse of psychotic disorder - two-years follow-up. 50th Annual Czech-Slovak Psychopharmacological Meeting, Jeseník Spa, 9-13 Jan 2008. Psychiatrie, 12; 2008, S1:30 and 38 poster.
  42. Kopeček M., Tišlerová B., Šóš P., Novák T., Horáček J., Brunovský M., Krajča V., Höschl C.: Antidepressant potential of cerebellar repetitive transcranial magnetic stimulation related to changes in theta prefrontal cordance. 50th Annual Czech-Slovak Psychopharmacological Meeting, Jeseník Spa, 9-13 Jan 2008. Psychiatrie, 12; 2008, S1:32.
  43. Páleníček T., Kutová M., Fujáková M., Brunovský M., Bubeníková-Valešová V., Tišlerová B., Šóš P., Horáček J., Höschl C.: Effect of psychotropics on quantitative EEG in rats. 50th Annual Czech-Slovak Psychopharmacological Meeting, Jeseník Spa, 9-13 Jan 2008. Psychiatrie, 12; 2008, S1:34.
  44. Kopeček M., Bareš M., Brunovský M., Novák T., Stopková P., Kožený J., Šóš P., Krajča V., HöschlC.: EEG cordance as a predictor of antidepressant response. 50th Annual Czech-Slovak Psychopharmacological Meeting, Jeseník Spa, 9-13 Jan 2008. Psychiatrie, 12; 2008, S1:41.
  45. Höschl C., Ruiz P., Cacas M., Musalek M., Gaebel W., Vavrušová L. The impact of migration on mental health and mental illness. Symposium: The impact of migration on mental health and mental illness. 1Tth AEP Congress, Nice, 5-9.4.2008. European Psychiatry, 23, 2008, S2:42
  46. Bubeníková-Valešová V., Votava M., Páleníček T., Horáček J., Höschl C.: Effect of Serotonin-1A receptor on behavioral changes in animal model of schizophrenia-like behavior. Symp.: The role of 5-HT1AR in pathophysiology and treatment of schizophrenia. 16th AEP Congress, Nice, 5-9.4.2008. European Psychiatry, 23, 2008, S2:61.
  47. Horáček J., Španiel F., Brunovský M., Novák T., Tišlerová B., Kopeček M., Mohr P., Höschl C.: The influence of polymorphism for Serotonin 5HT-1A receptor on phenotypic variables in schizophrenia. Symp.: The role of 5-HT1AR in pathophysiology and treatment of schizophrenia. 16th AEP Congress, Nice, 5-9.4.2008. European Psychiatry, 23, 2008, S2:61-62
  48. Bareš M., Brunovský M., Kopeček M., Novák T., Stopková P., Kožený J., Šóš P., Krajča V., Höschl C.: The decrease of prefrontal theta QEEG cordance value predicts response to Venlafaxine treatment in patients with resistant depression. Free Communications, 16th AEP Congress, Nice, 5-9.4.2008. European Psychiatry, 23, 2008, S2:74.
  49. Brunovský M., Tišlerová B., Šóš P., Horáček J., Klírová M., Novák T., Höschl C.: Topographic and tomographic QEEG changes induced by antipsychotic drugs. Symp. Characterization of second generation antipsychotic drugs: The role of electrophysiology. 16th AEP Congress, Nice, 5-9.4.2008. European Psychiatry, 23, 2008, S2:77.
  50. Španiel F., Hrdlička J., Novák T., Motlová L., Höschl C.: ITAREPS: Information technology aided relapse prevention programme in schizophrenia. A two-year mirror design follow up evaluation. Poster Session I: Schizophrenia and Psychosis.16th AEP Congress, Nice, 5-9.4.2008. European Psychiatry, 23, 2008, S2:148.
  51. Praško J., Horáček J., Houbová P., Kosová J., Klaschka J., Pašková B., Prašková H., Seifertová D., Vyskočilová J., Höschl C.: Moclobemide and cognitive behavioral therapy in the treatment of social phobia. Poster Session II: Cognitive Psychotherapy. 16th AEP Congress, Nice, 5-9.4.2008. European Psychiatry, 23, 2008, S2:302.
  52. Brunovský M., Horáček J., Novák T., Mohr P-, Tišlerová B., Šóš P., Höschl C.: Ketamine - NMDA receptor antagonist in the model of schizophrenia II: QEEG study. In: Raboch J. et al. (eds.) Quo vadis psychiatria? Proceedings of the 7th Congress of the Czech psychiatric association with international participation. Galén, Praha 2008, pp 14-17, ISBN 978-80-7262-567-3.
  53. Horáček J., Brunovský M., Novák T., Tintěra J., Ibrahim I., Španiel F., Mohr P., Höschl C. Ketamine-NMDA receptor antagonist in the model of schizophrenia I: fMRI study. In: Raboch J. et al. (eds.) Quo vadis psychiatria? Proceedings of the 7th Congress of the Czech psychiatric association with international participation. Galén, Praha 2008, pp 45-47. ISBN 978-80-7262-567-3
  54. Horáček J, Brunovský M,Tišlerová B,Novák T,Tintěra J,Ibrahim I, Španiel F,Mohr P, Höschl C: Ketamine influence on the brain acitivity detected using pharmaco-magnetic resonance in the model of schizophrenia. In:Raboch J.et al.(eds.) Quo vadis psychiatria? Proceedings of the 7th Congress of the Czech psychiatric association with intl. participation.Galén, Praha 2008, pp 47-49.ISBN 978-80-7262-567-3
  55. Horáček J., Španiel F., Seifertová D., Brunovský M., Mohr P., Höschl C.: NMDA receptor antagonists in the treatment of depression. In: Raboch J.et al.(eds.) Quo vadis psychiatria? Proceedings of the 7th Congress of the Czech psychiatric association with international participation.Galén, Praha 2008, pp 50-51.ISBN 978-80-7262-567-3
  56. Páleníček T., Brunovský M., Horáček J., Kutová M., Fujáková M., Bubeníková-Valešová V., Höschl C.: EEG coherence in the gama-band in animal model of psychoses. In: Raboch J.et al.(eds.) Quo vadis psychiatria? Proceedings of the 7th Congress of the Czech psychiatric association with international participation.Galén, Praha 2008, pp 136-137.ISBN 978-80-7262-567-3
  57. Höschl C.:, Perugi G., Akdeniz F., Vasquez G.H., Milev R.V.: Specific Issues in patients with bipolar disorder. XIV. World Congress of psychiatry, 20-25, September, 2008, Prague, Czech Republic. Česká a Slovenská Psychiatrie, 104; 2008, S2:374.
  58. Höschl C.: Discrete and continuous approach in the conceptualization of psychoses. XIV. World Congress of psychiatry, 20-25, September, 2008, Prague, Czech Republic. Česká a Slovenská Psychiatrie, 104; 2008, S2:375.
  59. Kopeček M., Bareš M., Brunovský M., Novák T., Stopková P., Šóš P., KoženýJ., Krajča V., Höschl C. EEG cordance as a predictor of response to antidepressivemedication - pooled analyses. XIV. World Congress of psychiatry, 20-25, September, 2008, Prague, Czech Republic. Česká a Slovenská Psychiatrie, 104; 2008, S2:1193.
  60. ŠpanielF., Kožený J., Hrdlička J., Motlová L., Novák T., Höschl C. ITAREPS: A new tool for relapse prevention in schizoprenia. XIV. World Congress of psychiatry, 20-25, September, 2008, Prague, Czech Republic. Česká a Slovenská Psychiatrie, 104; 2008, S2:1295.
  61. Höschl C., Praško J. Using multimedial tools, role playing and video feedback in the training of case management. XIV. World Congress of psychiatry, 20-25, September, 2008, Prague, Czech Republic. Česká a Slovenská Psychiatrie, 104; 2008, S2:1443.
  62. Höschl C., Stopková P. Discrete and continuous approaches in the conceptualization of schizophrenia and bipolar disorder. Abstract book, Psychiatric comorbidity: Implications for diagnosis and treatment, and 11th Central European Neuropsychopharmacological Symposium, Belgrade, Serbia, 19-22 October 2008, p.9-12.
  63. Höschl C.: European Psychiatry - Needs, Challenges and Structures - EPA perspective. DGPPN Kongress 2008 (Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheikunde), 26.-29 Nov., 2008, Berlin, Germany. Abstracts, p. 49
  64. Höschl C.: Art and (neuro)science. Czech and Slovak neurology and neurosurgery. 71, 2008; 104, S3: S84.
  65. Horáček J, Brunovský M, Tišlerová B, Novák T, Tintěra J, Ibrahim I, Höschl C. Experimental catatonia and its perception [in Czech]. Psychiatrie 13, 2009; S1:14
  66. Horáček J, Brunovský M, Novák T, Tintěra J, Ibrahim I, Španiel F, Klírová M, Tišlerová B, Höschl C. Antagonism on NMDA receptors in the model of schizophrenia: fMRI study in healthy volunteers [in Czech]. Psychiatrie 13, 2009; S1:33
  67. Höschl C.: Leadership in a changing Europe. European Psychiatry, abstracts on CD-ROM, 17th European Congress of Psychiatry, January 24-28, 2009, Lisbon, Portugal.
  68. M. Bares, M. Brunovsky, T. Novak, M. Kopecek, P. Stopkova, P. Sos, C. Höschl:PREDICTION OF RESPONSE TO BUPROPION TREATMENT - THE EARLY CHANGE OF PREFRONTAL QEEG CORDANCE. OPEN LABEL STUDY. European Psychiatry, abstracts on CD-ROM, 17th European Congress of Psychiatry, January 24-28, 2009, Lisbon, Portugal.
  69. Brunovsky M, Horacek J, Bares M, Novak T, Tislerova B, Sos P, Krajca V, Höschl C: Influence of Subanesthetic Dose of Ketamine on Theta Cordance in Healthy Volunteers: Implications for Antidepressant Effect. European Psychiatry, abstracts on CD-ROM, 17th European Congress of Psychiatry, January 24-28, 2009, Lisbon, Portugal.
  70. C. Höschl, P. Stopková: EPIDEMIOLOGY AND RISK FACTORS OF BIPOLAR DISORDER AND SCHIZOPHRENIA IN THE CONCEPTUALIZATION OF THE DISEASE SPECTRUM. European Psychiatry, abstracts on CD-ROM, 17th European Congress of Psychiatry, January 24-28, 2009, Lisbon, Portugal.
  71. Kopeček M, Brunovský M, Bareš M, Kožený J, Novák T, Stopková P, Šóš P, Krajča V, Höschl C. Můžeme predikovat efekt rTMS podle prefrontální EEG kordance?[Can we predict the effect of rTMS using prefrontal EEG cordance?] Psychiatrie 13, 2009; S2:53-54
  72. Höschl C, Hájek T. Morfologie deprese [Morphology of depression]. Psychiatrie, 13; 2009, S2:44.
  73. Höschl C., Hájek T. Morphology of depression. Psychiatrie, 13; 2009, S2:44.
  74. Bubeníková-Valešová V, Horáček J, Páleniček T, Valeš K, Höschl C. Improving cognitive function in animal models of schizophrenia: Focus on serotonin receptors. 9th World Congress of Biological Psychiatry, 28 June-2 July, 2009. Abstracts, p. 45
  75. Höschl C.: Ensuring data quality in multi-national clinical trials. The Journal of the European College of Neuropsychopharmacology19, 2009; Suppl.3:S717.
  76. Novak T., Hajek T., Kopecek M., Gunde E., Alda M., Hoschl C.: Subgenual cingulate volumes in offspring of bipolar parents. The Journal of the European College of Neuropsychopharmacology 19, 2009; Suppl.3:S 319.
  77. Bares M, Kopecek M, Novak T, Stopkova P, Sos P, Kozeny J, Brunovsky M, Höschl C. Right-sided, 1-Hz repetitive TMS compared with venlafaxine extended release in the treatment of resistant depression: a double-blind study. European Neuropsychopharmacology 19, 2009; Suppl.3:S 365.
  78. Höschl C.: Prediction of a treatment response to antidepressants. Book of abstracts, SiNAPSA Neuroscience Conference‘09, Faculty of Medicine, University of Ljubljana, Slovenia, 26-29 Sept. 2009.
  79. Höschl C., Španiel F.: Art and neuroscience: On evolutionary meaning of art and its neurobiological relevance. Abstracts, 3rd World Congress on Controversies in Neurology. Prague, Czech Republic, October 8-11, 2009: A17-18.
  80. Höschl C. Recommended guidance beyond guidelines. Abstracts of 1st International Congress on Neurobiology and Clinical Psychopharmacology & EPA conference on Treatment Guidance. Thessaloniki, Greece,19-22 November 2009, p.61
  81. Bareš M., Novák T., Kopeček M., Šóš P., Stopková P., Brunovský m., Kožený J., Höschl C.: Pravostranná, nízkofrekvenční (1Hz) repetitivní transkraniální magentická stimulace (rTMS) v léčbě rezistentní deprese v porovnání s venlafaxinem ER. Výsledky dvojitě slepé, randomizované studie. Psychiatrie, 13, 2009, Suppl 2.58.
  82. Brunovský M, Bareš M, Novák T, Kopeček M, Horáček J, Krajča V, Höschl C. The reduction of prefrontal QEEG Theta cordance as a predictor of treatment response in patients with resistant major depression: a pooled analysis of single-center studies with Bupropion, Venlafaxine and rTMS. Clinical EEG and Neurosicence, 40, 2009; 4:308.
  83. Brunovský M, Horáček J, Bareš M, Novák T, Tišlerová B, Šóš P, Krajča V, Höschl C.: Influence of subanaesthetic dose of ketamine on theta cordance in healthy volunteers: implications for antidepressant effect. European Psychiatry, 24; 2009, Suppl 1:550.
  84. Brunovský M, Kopeček M, Bareš M, Kožený J, Novák T, Stopková P, Šóš P, Krajča V, Höschl C. QEEG prediction of response to rTMS and/or venlafaxine in patients with depressive disorder. A double-blind, single-centre, randomized study. 9th World congress of Biological Psychiatry, Paris 28 June-2 July, 2009. Abstracts: 226-227
  85. Kopeček M, Brunovský M, Bareš M, Kožený J, Novák T, Stopková P, Šóš P, Krajča V, Höschl C: QEEG prediction of response to rTMS and/or Venlafaxine in patients with depressive disorder. A Double-blind, single-centre, randomized study. Biological psychiatry 65; 2009:222.
  86. Novák T., Hájek T., Kopeček M., Gunde E., Alda M., Höschl C. Objemy subgenuálního cingula u potomků rodičů s bipolární poruchou. Psychiatrie, 13; 2009, Suppl. 2:58-59.
  87. Horáček J, Brunovský M, Novák T, Tintěra J, Ibrahim I, Španiel F, Klírová M, Tišlerová B, Bubeníková-Valšová V, Minárik M, Páleníček T, Höschl C. The influence of polymorphism for 5HT1A receptor on functional and morphological phenotype in schizophrenia: VBM, FMRI and PET study. Psychiatrie 14, 2010; S1:12
  88. Höschl C. Prediction of a therapeutic response – dawn of better times? [in Czech]. Psychiatrie 14, 2010; S1:18-19
  89. Brunovský M, Bareš M, Novák T, Kopeček M, Stopková P, Krajča V, Šóš P, Höschl C. History of an inconspicuous discovery (on cordance and prediction) [in Czech]. Psychiatrie 14, 2010; S1:19
  90. Bareš M, Brunovský M, Novák T, Kopeček M, Stopková P, Krajča V, Šóš P, Höschl C. QEEG cordance as a tool of prediction of therapeutic response to antidepressants in treatment-resistant depressed patients [in Czech]. Psychiatrie 14, 2010; S1:19-20
  91. Horáček J, Brunovský M, Novák T, Tintěra J, Ibrahim I, Španiel F, Klírová M, Tišlerová B, Höschl C. Acute administration of ketamine in human model of schizophrenia [in Czech]. Psychiatrie 14, 2010; S1:20
  92. Horáček J, Tintěra J, Ibrahim I, Holec M, Verébová K, Kopřivová J, Brunovský M, Novák T, Klírová M, Tišlerová B, Höschl C. Use of fMRI in assessment of emotional stimuli processing [in Czech]. Psychiatrie 14, 2010; S1:28
  93. Novák T, Hájek T, Kopeček M, Horáček J, Höschl C. Voxel-based morphometry in affected and non-affected offsprings of parents with bipolar affective disorder [in Czech]. Psychiatrie 14, 2010; S1:39
  94. Höschl C.: Teaching Medical Students Psychiatry in Central Europe. Symposium "Training Undergraduates in Psychiatry in the twenty first century" (28th Feb). 18th EPA Congress of Psychiatry, abstracts on CD-Rom. Eur Psychiatry, 25, 2010; (S1)
  95. Höschl C.: Recent Developments in the Treatment of Schizophrenia. Update on lecture, 18th EPA Congress of Psychiatry, abstracts on CD-Rom. Eur Psychiatry, 25, 2010; (S1)
  96. Volavka J, Mohr P, Hoschl C.: Interesting, particularly if true: Critical analysis of two publications. In: Raboch et al. (eds.), Abstracts, VIIIth Congress of the Czech Psychiatric Association, Spindleruv Mlyn, 10-13 June 2010
  97. Novák T, Kopecek M, Horacek J, Hajek T, Hoschl C. Voxel-based morphometry in affected and unaffected offspring of bipolar parents. 23rd ECNP Congress, 28.8.-1.9.2010, Amsterdam, The Netherlands. European Neuropsychopharmacology, 20; 2010, Suppl 3:S303.
  98. Horacek J, Brunovsky M, Tislerova B, Novak T, Spaniel F, Tintera J, Dezortova M, Höschl C. The ins and outs of ketamine model of schizophrenia QEEG and fMRI study in healthy volunteers. Abstracts, 16th Biennial IPEG Congress, 7-10 Oct 2010, Prague, Czech Republic
  99. Brunovsky M, Bares M, Novak T, Kopecek M, Sos P, Krajca V, Höschl C. the change of prefrontal QEEG cordance as a predictor of response to antidepressant treatment. Abstracts, 16th Biennial IPEG Congress, 7-10 Oct 2010, Prague, Czech Republic
  100. Kopřivová J, Congedo M, Horáček J, Praško J, Raszka M, Brunovský M, Tišlerová B, Höschl C. EEG source analysis in obsessive-compulsive disorder. Abstracts, 16th Biennial IPEG Congress, 7-10 Oct 2010, Prague, Czech Republic

Previous | 1 | 2 | 3 | 4 | Next  Move up